Hisamitsu Pharmaceutical CoFSE:4530 89 Days Inventory is 140.50 as of Nov. 2025, which is 21% above its 10-year median of 116.28. GuruFocus rates FSE:4530 with a GF Score™ of 89/100 and a GF Value™ of 円3,237.07. Among 916 Drug Manufacturers companies, Hisamitsu Pharmaceutical Co ranks better than 62.45% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hisamitsu Pharmaceutical Co's Inventory Turnover for the
three
months ended in Nov. 2025 was 0.65.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hisamitsu Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Nov. 2025 was 0.64.
Hisamitsu Pharmaceutical Co (FSE:4530) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Hisamitsu Pharmaceutical Co's Inventory Turnover for the
three
months ended in Nov. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hisamitsu Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Nov. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Hisamitsu Pharmaceutical Co Days Inventory Related Terms
Hisamitsu Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FSE:4530 vs ESPR, AMPH, ETON: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hisamitsu Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Hisamitsu Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hisamitsu Pharmaceutical Co (FSE:4530) has a Days Inventory of 140.50 as of Nov. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hisamitsu Pharmaceutical Co and its competitors. This is 21% above median its historical median of 116.28. Over the past decade, Hisamitsu Pharmaceutical Co's Days Inventory has ranged from 106.71 to 136.97. According to the industry distribution chart, Hisamitsu Pharmaceutical Co ranks #344 out of 916 companies in the Drug Manufacturers industry, placing it in the top 37.6%.
Is Hisamitsu Pharmaceutical Co's Days Inventory too high?
Hisamitsu Pharmaceutical Co's current Days Inventory of 140.50 is 21% above median its 10-year median of 116.28. Over the past 10 years, this metric has ranged from a low of 106.71 to a high of 136.97. The Drug Manufacturers industry median Days Inventory is 164.43. Hisamitsu Pharmaceutical Co's value of 140.50 is 14.6% below this industry median. Based on the distribution chart, Hisamitsu Pharmaceutical Co ranks #344 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's Days Inventory compare to ESPR and AMPH?
According to the Drug Manufacturers industry distribution chart, Hisamitsu Pharmaceutical Co ranks #344 out of 916 companies for Days Inventory. This puts Hisamitsu Pharmaceutical Co in the upper half of its industry. The industry median Days Inventory is 164.43. Hisamitsu Pharmaceutical Co's value of 140.50 is 14.6% below this benchmark. Historically, Hisamitsu Pharmaceutical Co's own Days Inventory has ranged from 106.71 to 136.97 over the past decade. While the company's 10-year median is 116.28 vs. the industry median of 164.43, Hisamitsu Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hisamitsu Pharmaceutical Co's current Days Inventory of 140.50 is 14.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hisamitsu Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hisamitsu Pharmaceutical Co's current Days Inventory is 140.50, which is 21% above median its own 10-year median of 116.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current Days Inventory of 140.50. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current Days Inventory is 140.50, which is 21% above median its 10-year median of 116.28 and 14.6% below the Drug Manufacturers industry median of 164.43. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current Days Inventory is 140.50 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?
Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.
Key valuation signals for FSE:4530:
Days Inventory: 140.50 (21% above median its 10-year median of 116.28)
GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
Industry Position: 14.6% below the Drug Manufacturers median (#344 of 916)
No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score
Get the complete analysis for FSE:4530
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSE:4530 has been successfully added to your 
